NCT06397846View on ClinicalTrials.gov

Identification of Biomarkers Associated With the Presence of Malignant Pancreatic Lesions Compared to Benign Lesions.

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 11, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

June 30, 2027

Conditions
Benign Pancreatic Lesion
Interventions
OTHER

Biological sample

blood sample will be collected at baseline

Trial Locations (2)

Unknown

RECRUITING

University Hospital of Besancon, Besançon

NOT_YET_RECRUITING

Hôpital Nord Franche-Comté, Montbéliard

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Besancon

OTHER